Profile data is unavailable for this security.
About the company
Vivimed Labs Limited is an India-based company engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. The Company is primarily engaged in Pharma segment. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. Its manufacturing facilities are equipped to deliver a range of dosage delivery formats that include capsules, tablets, syrups & liquids, sprays & ointments.
- Revenue in INR (TTM)1.04bn
- Net income in INR-243.69m
- Incorporated1988
- Employees586.00
- LocationVivimed Labs LtdNorth End, Road No. 2,, Banjara Hills,HYDERABAD 500034IndiaIND
- Phone+91 4 066086608
- Fax+91 4 066086699
- Websitehttps://www.vivimedlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lasa Supergenerics Ltd | 952.91m | -361.68m | 447.40m | 66.00 | -- | 0.7941 | -- | 0.4695 | -7.57 | -7.57 | 19.58 | 11.25 | 0.8705 | 6.06 | 36.08 | 14,437,960.00 | -33.04 | -6.42 | -46.76 | -8.54 | 22.28 | 28.58 | -37.96 | -8.05 | 0.5203 | -14.70 | 0.1152 | -- | 36.53 | -3.16 | 32.09 | -- | -- | -- |
| Vilin Bio Med Ltd | 199.81m | 2.51m | 473.60m | -- | 188.20 | 2.04 | 133.30 | 2.37 | 0.1804 | 0.1804 | 14.34 | 16.64 | 0.6845 | 3.65 | 3.25 | -- | 0.8592 | 1.81 | 1.08 | 2.70 | 6.60 | 21.72 | 1.26 | 2.71 | 4.16 | 1.19 | 0.0193 | -- | -6.30 | -2.51 | 37.62 | 6.62 | 130.50 | -- |
| Mangalam Drugs and Organics Ltd | 2.38bn | -309.21m | 517.43m | 414.00 | -- | -- | -- | 0.217 | -19.53 | -19.53 | 150.57 | -- | -- | -- | -- | 5,758,911.00 | -- | 2.90 | -- | 5.34 | 39.15 | 29.02 | -12.97 | 2.46 | -- | -0.9827 | -- | -- | -13.66 | 2.42 | 174.27 | -4.02 | 23.85 | -- |
| Biofil Chemicals and Pharmaceuticals Ltd | 425.20m | 28.59m | 584.39m | 26.00 | 20.49 | 2.74 | 18.42 | 1.37 | 1.75 | 1.75 | 25.87 | 13.09 | 0.8731 | 7.84 | 1.28 | 16,353,690.00 | 5.87 | 2.13 | 14.16 | 4.33 | 5.22 | 8.63 | 6.72 | 2.33 | 1.33 | 8.28 | 0.0009 | -- | -16.57 | 2.38 | -21.36 | -14.31 | -13.50 | -- |
| Vineet Laboratories Ltd | 570.37m | -166.97m | 590.98m | -- | -- | 2.36 | -- | 1.04 | -15.30 | -15.30 | 52.08 | 13.02 | 0.5785 | 1.01 | 4.23 | -- | -16.94 | -1.82 | -54.66 | -5.75 | 4.86 | 19.76 | -29.27 | -1.09 | 0.1186 | -3.06 | 0.7505 | -- | -50.20 | -- | -2,065.83 | -- | -- | -- |
| Vivimed Labs Ltd | 1.04bn | -243.69m | 614.39m | 586.00 | -- | -- | -- | 0.5901 | -2.93 | -2.93 | 12.54 | -5.78 | 0.1115 | 0.8832 | 1.17 | 1,776,860.00 | -2.60 | -9.00 | -4.80 | -13.91 | 51.93 | 27.65 | -23.29 | -35.17 | 0.6624 | -5.54 | 1.14 | -- | -22.00 | -35.71 | 29.67 | -- | -47.43 | -- |
| Onyx Biotec Ltd | 663.87m | 10.68m | 643.69m | -- | 30.50 | 1.18 | 15.54 | 0.9696 | 1.16 | 1.16 | 44.50 | 30.18 | 0.7814 | 3.90 | 2.95 | -- | 1.26 | -- | 1.90 | -- | 29.72 | -- | 1.61 | -- | 1.35 | 2.13 | 0.2233 | -- | 15.26 | -- | 36.31 | -- | -- | -- |
| Accretion Pharmaceuticals Ltd | 573.76m | 67.94m | 761.45m | 121.00 | 11.21 | 4.98 | 10.06 | 1.33 | 6.11 | 6.11 | 51.62 | 13.75 | -- | -- | -- | 4,741,835.00 | -- | -- | -- | -- | 30.44 | -- | 11.84 | -- | 0.557 | 8.30 | 0.4799 | -- | 70.43 | -- | 75.30 | -- | -- | -- |
Data as of Feb 16 2026. Currency figures normalised to Vivimed Labs Ltd's reporting currency: Indian Rupee INR
